Department of Clinical Laboratory, University of Yamanashi Hospital, Chuo, Japan.
Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan.
J Thromb Haemost. 2021 Jun;19(6):1572-1584. doi: 10.1111/jth.15317. Epub 2021 Apr 20.
Erythropoiesis is a complex multistep process by which erythrocytes are produced. C-type lectin-like receptor 2 (CLEC-2) is a podoplanin (PDPN) receptor almost exclusively expressed on the surface of platelets and megakaryocytes. Deletion of megakaryocyte/platelet CLEC-2 was reported to cause anemia along with thrombocytopenia in mice. PDPN-expressing stromal cells in the bone marrow (BM) were also reported to facilitate megakaryocyte expansion and maturation depending on the CLEC-2/PDPN interaction.
We investigated how specific deletion of CLEC-2 in megakaryocytes/platelets leads to anemia.
We used flow cytometry to analyze maturation of erythroblasts, apoptotic cell death, and cell cycle distribution. CLEC-2 stimulated PDPN-expressing stromal cell-conditioned medium was analyzed by cytokine array and ELISA, and co-cultured with immature erythroblasts. Cytokine levels in serum and BM extracellular fluid were quantified by ELISA.
We observed increased apoptosis of BM erythroblasts in megakaryocyte/platelet-specific CLEC-2 conditional knockout (Clec1b ) mice. Moreover, PDPN-expressing stromal cells in the BM secreted insulin-like growth factor 1 (IGF-1) depending on the CLEC-2/PDPN interaction. Pretreatment with IGF-1 receptor inhibitor increased apoptosis rate and decreased the proliferation of erythroblasts in vitro. Furthermore, in Clec1b mice, IGF-1 concentrations in serum and BM extracellular fluid were decreased, and IGF-1 replacement in Clec1b mice attenuated anemia.
Our findings suggest that IGF-1 secretion from PDPN-expressing stromal cells by CLEC-2 stimulation positively regulates erythroblasts. This novel mechanism of erythropoiesis regulation indicates that a microenvironment consisting of megakaryocytes and PDPN-expressing stromal cells supports erythropoiesis.
红细胞的生成是一个复杂的多步骤过程。C 型凝集素样受体 2(CLEC-2)是一种几乎仅在血小板和巨核细胞表面表达的 podoplanin(PDPN)受体。据报道,巨核细胞/血小板 CLEC-2 的缺失会导致小鼠贫血伴血小板减少。骨髓(BM)中表达 PDPN 的基质细胞也据报道可通过 CLEC-2/PDPN 相互作用促进巨核细胞的扩增和成熟。
我们研究了巨核细胞/血小板中 CLEC-2 的特异性缺失如何导致贫血。
我们使用流式细胞术分析红细胞的成熟、细胞凋亡和细胞周期分布。通过细胞因子阵列和 ELISA 分析 CLEC-2 刺激的 PDPN 表达基质细胞条件培养基,并与未成熟的红细胞共培养。通过 ELISA 定量血清和 BM 细胞外液中的细胞因子水平。
我们观察到在巨核细胞/血小板特异性 CLEC-2 条件性敲除(Clec1b)小鼠的 BM 红细胞中凋亡增加。此外,BM 中表达 PDPN 的基质细胞会根据 CLEC-2/PDPN 相互作用分泌胰岛素样生长因子 1(IGF-1)。IGF-1 受体抑制剂预处理可增加体外红细胞凋亡率并降低其增殖率。此外,在 Clec1b 小鼠中,血清和 BM 细胞外液中的 IGF-1 浓度降低,而在 Clec1b 小鼠中补充 IGF-1 可减轻贫血。
我们的发现表明,CLEC-2 刺激表达 PDPN 的基质细胞分泌的 IGF-1 可正向调节红细胞。这种新的红细胞生成调节机制表明,由巨核细胞和表达 PDPN 的基质细胞组成的微环境支持红细胞生成。